OMB Individually Reported

AI Editing Tool

Low riskExact public inventory row

Description

This AI model is designed to detect style and formatting inconsistencies in FDA draft documents by comparing them against the FDA CDER Style Guide standards. It solves the problem of manual quality control inefficiencies and ensures consistent adherence to established documentation standards across all FDA CDER publications.

Detailed example

AI-identified style and formatting issues

AI / analytics pattern

Generative AI: AI that generates new or synthetic content (e.g., images, videos, audio, text, code).

Automation level / stage

b) Pilot – The use case has been deployed in a limited test or pilot capacity.

Expected benefit

It significantly reduces the workload for FDA editors by identifying style and formatting issues; however, human review remains essential, especially for important documents, ensuring both efficiency and quality in FDA communications.

Controls / human review

ATO: No; PIA: Not published

Data needed

CDER Style Guide